The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
J. Bousquet,
Groupe d’experts français desloratadine : Pr Jean Bousquet (modérateur), Institut Pasteur de Paris et hôpital A.-de-Villeneuve, Montpellier, France Pr Antoine Magnan, hôpital Sainte-Marguerite, Marseille, France Pr José Manuel Tunon de Lara, hôpital Haut-Lévêque, Bordeaux, France Pr Alain Didier, hôpital Larrey, Toulouse, France Dr François Wessel, Nantes, France Pr Frédéric de Blay, hôpital Lyautey, Strasbourg, France Pr Philippe Devillier, hôpital Maison-Blanche, Reims, France Pr Jean-Michel Klossek, hôpital de la Miletrie, Poitiers, France
L'EAACI (European Academy of Allergy and Clinical Immunology) et l'initiative ARIA (Allergic Rhinitis and its Impact on Asthma) ont defini les criteres auxquels doivent repondre les antihistaminiques H1 oraux de premiere intention dans les rhinites allergiques. Un groupe d'experts a examine les proprietes de la desloratadine dans cette indication et verifie leur coherence avec ces criteres en se fondant...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.